Anti-tumor necrosis factor therapy increases serum adiponectin levels with the improvement of endothelial dysfunction in patients with rheumatoid arthritis

• KOMAI Norio

  Division of Nephrology and Rheumatology, Department of Internal Medicine, Kawasaki Medical School

• MORITA Yoshitaka

  Division of Nephrology and Rheumatology, Department of Internal Medicine, Kawasaki Medical School

• SAKUTA Takeo

  Division of Nephrology and Rheumatology, Department of Internal Medicine, Kawasaki Medical School

• KUWABARA Atsunori

  Division of Nephrology and Rheumatology, Department of Internal Medicine, Kawasaki Medical School

• KASHIHARA Naoki

  Division of Nephrology and Rheumatology, Department of Internal Medicine, Kawasaki Medical School

収録刊行物

• Modern rheumatology

  Modern rheumatology 17 (5), 385-390, 2007-10-01

キーワード

• Adiponectin
• Anti-TNF therapy
• Endothelial function
• Infliximab
• Rheumatoid arthritis

詳細情報

• CRID: 1571135650465930496
• NII論文ID: 10019778138
• NII書誌ID: AA1157187X
• ISSN: 14397595
• Web Site: https://search.jamas.or.jp/link/ui/2008115378
• 本文言語コード: en
• データソース種別:
  • CiNii Articles